CCA cell apoptosis was induced by regorafenib through the caspase-mediated mitochondrial pathway, as demonstrated by elevated levels of cleaved caspase 3, 9 and PARP (Figure 1F). The gene discussed is CASP3; the disease is cholangiocarcinoma.